Revvity Inc. (RVTY) Stock Analysis

    $RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH

    Revvity (RVTY), a DIAGNOSTICS & RESEARCH company, has a market capitalization of about $17.03B and trades at 72.7x trailing earnings.

    Price

    $152.64

    Market cap

    $17.03B

    P/E ratio

    72.7x

    Dividend yield

    0.19%

    About Revvity Inc.

    Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.

    How StockWorthy values RVTY

    StockWorthy forecasts Revvity Inc.'s revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from RVTY's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.

    Related stocks

    Danaher Corporation$DHRIDEXX Laboratories Inc$IDXXIllumina Inc$ILMNIQVIA Holdings Inc$IQVBillionToOne, Inc. Class A Common Stock$BLLN

    See RVTY's Fair Value

    Create a free account to view Revvity Inc.'s base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.

    Create Free AccountSign In